BioMedBridges — LLMpedia

BioMedBridges
Name	BioMedBridges
Formation	2011
Dissolution	2015
Type	Research infrastructure project
Headquarters	Heidelberg
Region served	Europe
Parent organization	European Commission Seventh Framework Programme

Contents

BioMedBridges BioMedBridges was a European research infrastructure project linking major biomedical data resources to support translational research across institutions such as European Molecular Biology Laboratory, European Bioinformatics Institute, Max Planck Society, Karolinska Institutet, and Wellcome Trust Sanger Institute. Funded by the European Commission under the Seventh Framework Programme, the project coordinated technical work among infrastructure projects like ELIXIR, BBMRI-ERIC, LifeWatch, EATRIS, and Transnational Access. It sought to bridge data silos maintained by repositories including ArrayExpress, PRIDE (proteomics), European Genome-phenome Archive, UniProt, and Human Protein Atlas to enable cross-resource queries and workflows used by research centers such as Institute Pasteur, CNRS, Karlsruhe Institute of Technology, and EMBL-EBI.

Overview

BioMedBridges operated as a multi-partner consortium that targeted interoperability between research infrastructures and major databases like European Nucleotide Archive, Protein Data Bank, Reactome, OMIM, and ChEMBL. The project timeline overlapped with initiatives including Human Brain Project, Human Cell Atlas, BBMRI, Euro-BioImaging, and Cancer Core Europe, positioning BioMedBridges as a connector among data providers such as European Clinical Research Infrastructure Network, ClinicalTrials.gov, and regional biobanks affiliated with University of Cambridge, Karolinska University Hospital, Charité – Universitätsmedizin Berlin, and University of Oxford.

Objectives included harmonizing metadata models used by repositories like Ensembl, GenBank, ArrayExpress, PRIDE (proteomics), and MetaboLights; enabling secure data access compatible with legal frameworks referenced by European Commission policy and oversight from bodies such as European Medicines Agency and ethics committees at institutions like University College London and Heidelberg University Hospital. Scope encompassed technical deliverables for services integrating resources such as UniProtKB, Pfam, InterPro, Reactome, and clinical datasets from partners including Karolinska Institutet, Netherlands Cancer Institute, Institut Curie, and Institut Pasteur.

Technical architecture emphasized service-oriented integration using components like web services, APIs, authentication and authorization infrastructures inspired by OpenID Connect, OAuth 2.0, and federated identity approaches used by eduGAIN and Shibboleth. Middleware components referenced architectures from Apache Hadoop, Apache Spark, Django, and RESTful API design patterns while connecting to databases like Oracle Corporation deployments and MySQL instances maintained at centers such as European Bioinformatics Institute. The project prototyped data access layers, mapping frameworks, and workflow orchestration compatible with tools from Galaxy (computational biology), Taverna (software), Nextflow, and visualization platforms used at Max Planck Society laboratories.

BioMedBridges prioritized adoption and mapping of community standards including MIAME, MIAPE, FAIR principles, Dublin Core, ISA-Tab, HL7, FHIR, and ontologies from Gene Ontology Consortium, Sequence Ontology, ChEBI, SNOMED CT, and Human Phenotype Ontology. Interoperability work involved crosswalks among formats such as FASTQ, BAM (file format), VCF, mzML, mzIdentML, and metadata schemas found in BioSamples database and European Genome-phenome Archive. Governance dialogues engaged organizations like Global Alliance for Genomics and Health, ELIXIR, European Commission Directorate-General for Research and Innovation, and national funders including NIH-aligned European programs.

Pilot projects demonstrated integrated query and analysis across molecular, proteomic, and clinical repositories connecting platforms such as ArrayExpress, PRIDE (proteomics), UniProt, Reactome, Ensembl, and hospital records at Karolinska University Hospital, University College London Hospitals, and Charité – Universitätsmedizin Berlin. Use cases included biomarker discovery workflows used by Cancer Research UK partners, infectious disease surveillance aligned with European Centre for Disease Prevention and Control, and translational research pipelines relevant to consortia like IMI projects and Human Proteome Project collaborations.

Although the project ended in 2015, its outcomes influenced successor infrastructures and policy dialogues involving ELIXIR, BBMRI-ERIC, Global Alliance for Genomics and Health, and European research programs coordinated by the European Commission. Tools, standards mappings, and demonstration workflows informed operational services at EMBL-EBI, UniProt Consortium, European Genome-phenome Archive, and national infrastructures in Germany, Sweden, France, United Kingdom, and Netherlands. The project's emphasis on federated access, standards such as FAIR principles, and cross-infrastructure collaboration shaped subsequent initiatives including Human Cell Atlas, Human Brain Project, and transnational data-sharing policies promoted by the European Research Area.

Category:Biomedical research projects